Cancer Health Treatment Update A Cancer Story: The 5-Year Mark Megan-Claire Chase officially reached the five-year mark of her breast cancer surgery and was flooded with memories. FDA Approves Immunotherapy for Endometrial Cancer New checkpoint inhibitor Jemperli is approved for cancers with deficient mismatch repair mechanism for fixing damaged DNA. Challenges of Navigating Cancer as a Member of the LGBTQ+ Community When it comes to cancer, LGBTQ+ people often come up against additional hurdles that are not faced by those who are cisgender and heterosexual. News From the American Association for Cancer Research Annual Meeting See our latest reports on cancer diagnosis, new therapies, disparities in care and more. Advertisement U.S. Resumes Use of Johnson & Johnson COVID-19 Vaccine Despite rare reports of unusual blood clots, the CDC and FDA confirmed that the vaccine is safe, and said the recent pause should be lifted for all groups. More News About COVID-19 See all Cancer Health coverage of COVID-19, including how it affects people living with cancer. For more news about the SARS-CoV-2 coronavirus, visit our sister site, COVID Health.com. Cancer Health Spring 2021 Check out our latest print edition! Newsfeed Challenges of Navigating Cancer as a Member of the LGBTQ+ Community Tackling Unconscious Bias in Surgical Oncology U.S. Resumes Use of Johnson & Johnson COVID-19 Vaccine Medical Financial Hardship Common in Adult Survivors of Adolescent Cancers Blog: Food and Drug Administration (FDA) FDA Approves Immunotherapy for Endometrial Cancer with Specific Biomarker FDA Approves First Immunotherapy for Initial Treatment of Stomach Cancer FDA Approves New Sarclisa Regimen for Multiple Myeloma FDA Approves Yescarta for Follicular Lymphoma Newsfeed Challenges of Navigating Cancer as a Member of the LGBTQ+ Community Tackling Unconscious Bias in Surgical Oncology U.S. Resumes Use of Johnson & Johnson COVID-19 Vaccine Medical Financial Hardship Common in Adult Survivors of Adolescent Cancers Blog: Food and Drug Administration (FDA) FDA Approves Immunotherapy for Endometrial Cancer with Specific Biomarker FDA Approves First Immunotherapy for Initial Treatment of Stomach Cancer FDA Approves New Sarclisa Regimen for Multiple Myeloma FDA Approves Yescarta for Follicular Lymphoma

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to newsletter@newslettercollector.com by update@cancerhealth.com. Please remember to add update@cancerhealth.com to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is: